The Fund Grade · free · no account needed
What grade does POAGX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
PRIMECAP Odyssey Aggressive Growth
#248 of 500 graded active funds · growth · large segment peer group
The point · specialist footprint
POAGX puts more of its book behind proven specialists than 64% of graded funds.
Bottom 20%
Bottom 40%
Middle
● Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8% per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
10,000+ funds tracked · the graded specialists among them drive every read
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
POAGX vs the Honor Roll · share card ↗Conviction exposure
33.8%
of the book in specialist-converged names
Late-stage weight
21.3%
of the book in Crowded or Fading names
Active share
88.1%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
POAGX lands at C grade, ranked 248 of 500, with specialists holding only a third of the book. The brightest spot is a 10.5% position in MU at Early Conviction stage, paired with NVDA. The concern is real weight in Fading names like FLEX, RYTM, and TSLA, where specialists are already heading for the exit.
→ Watch the combined 9.0% in Fading positions, FLEX, RYTM, JBL, and TSLA, for continued specialist selling as a signal to reassess.
→ Compare this C grade against the 3 higher graded funds in the same segment, and check if a better graded option exists within the PRIMECAP family.
Support leaving these positions
Same family, higher grade
Read from today's disclosed book. Evidence, not advice.